Article info
PDFClinical ethics
Views of patients with heart failure about their role in the decision to start implantable cardioverter–defibrillator treatment: prescription rather than participation
- Correspondence to: Dr A S Ågård Department of Medicine, Sahlgrenska University Hospital/Sahlgrenska Hospital, Göteborg 41345, Sweden; anders.s.agard{at}vgregion.se
Citation
Views of patients with heart failure about their role in the decision to start implantable cardioverter–defibrillator treatment: prescription rather than participation
Publication history
- Received June 5, 2006
- Accepted September 1, 2006
- First published August 30, 2007.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by the Journal of Medical Ethics
Other content recommended for you
- Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation
- Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period
- Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients
- Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score
- Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender
- Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience
- Republished: How to reduce sudden cardiac death in patients with renal failure
- How to reduce sudden cardiac death in patients with renal failure
- The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
- Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis